Market closed
IceCure Medical/$ICCM
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About IceCure Medical
Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.
Ticker
$ICCM
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Caesarea, Israel
Employees
74
Website
IceCure Medical Metrics
BasicAdvanced
$51M
Market cap
-
P/E ratio
-$0.29
EPS
2.63
Beta
-
Dividend rate
Price and volume
Market cap
$51M
Beta
2.63
52-week high
$1.57
52-week low
$0.48
Average daily volume
871K
Financial strength
Current ratio
2.67
Quick ratio
2.164
Long term debt to equity
2.207
Total debt to equity
4.831
Management effectiveness
Return on assets (TTM)
-52.54%
Return on equity (TTM)
-111.35%
Valuation
Price to revenue (TTM)
12.366
Price to book
5.12
Price to tangible book (TTM)
5.12
Price to free cash flow (TTM)
-4.207
Growth
Revenue change (TTM)
26.02%
Earnings per share change (TTM)
-19.95%
3-year revenue growth (CAGR)
-5.38%
3-year earnings per share growth (CAGR)
-3.94%
What the Analysts think about IceCure Medical
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for IceCure Medical stock.
IceCure Medical Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
IceCure Medical Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
IceCure Medical News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for IceCure Medical stock?
IceCure Medical (ICCM) has a market cap of $51M as of December 14, 2024.
What is the P/E ratio for IceCure Medical stock?
The price to earnings (P/E) ratio for IceCure Medical (ICCM) stock is 0 as of December 14, 2024.
Does IceCure Medical stock pay dividends?
No, IceCure Medical (ICCM) stock does not pay dividends to its shareholders as of December 14, 2024.
When is the next IceCure Medical dividend payment date?
IceCure Medical (ICCM) stock does not pay dividends to its shareholders.
What is the beta indicator for IceCure Medical?
IceCure Medical (ICCM) has a beta rating of 2.63. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.